Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
D 8.81 -2.87% -0.26
SRNE closed down 2.87 percent on Thursday, March 4, 2021, on approximately normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical SRNE trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -2.87%
Oversold Stochastic Weakness -2.87%
50 DMA Resistance Bearish -6.67%
Multiple of Ten Bearish Other -6.67%
Outside Day Range Expansion -6.67%
Wide Bands Range Expansion -6.67%
Older End-of-Day Signals for SRNE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 9 hours ago
Fell Below 200 DMA about 9 hours ago
1.5x Volume Pace about 10 hours ago
200 DMA Support about 10 hours ago
Down 5% about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sorrento Therapeutics, Inc. Description

Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Biology Immunology Immune System Infectious Diseases Disease Treatment Of Cancer Monoclonal Antibody Inflammation Antibody Therapeutic Product Library Opko Health Antibody Therapy

Is SRNE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.39
52 Week Low 1.55
Average Volume 19,484,223
200-Day Moving Average 8.59
50-Day Moving Average 10.56
20-Day Moving Average 12.56
10-Day Moving Average 10.53
Average True Range 1.30
ADX 30.08
+DI 18.63
-DI 31.56
Chandelier Exit (Long, 3 ATRs ) 13.36
Chandelier Exit (Short, 3 ATRs ) 12.13
Upper Bollinger Band 17.34
Lower Bollinger Band 7.79
Percent B (%b) 0.11
BandWidth 75.95
MACD Line -0.64
MACD Signal Line 0.04
MACD Histogram -0.6723
Fundamentals Value
Market Cap 2.32 Billion
Num Shares 263 Million
EPS -2.40
Price-to-Earnings (P/E) Ratio -3.66
Price-to-Sales 40.11
Price-to-Book 10.20
PEG Ratio -0.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.10
Resistance 3 (R3) 10.05 9.58 9.89
Resistance 2 (R2) 9.58 9.25 9.60 9.81
Resistance 1 (R1) 9.19 9.05 9.39 9.24 9.74
Pivot Point 8.72 8.72 8.81 8.74 8.72
Support 1 (S1) 8.33 8.39 8.53 8.38 7.88
Support 2 (S2) 7.86 8.19 7.88 7.81
Support 3 (S3) 7.47 7.86 7.74
Support 4 (S4) 7.52